NCT04071626: A reported trial by University Hospitals Cleveland Medical Center
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04071626 |
|---|---|
| Title | The EMMED-HF Study: Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 1, 2020 |
| Completion date | Jan. 11, 2023 |
| Required reporting date | Jan. 11, 2024, midnight |
| Actual reporting date | Oct. 12, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |